Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Lead In Phase	STARTED	Lead In Phase	21
Lead In Phase	STARTED	Sapacitabine-decitabine Alternating	0
Lead In Phase	STARTED	Decitabine	0
Lead In Phase	COMPLETED	Lead In Phase	21
Lead In Phase	COMPLETED	Sapacitabine-decitabine Alternating	0
Lead In Phase	COMPLETED	Decitabine	0
Lead In Phase	NOT COMPLETED	Lead In Phase	0
Lead In Phase	NOT COMPLETED	Sapacitabine-decitabine Alternating	0
Lead In Phase	NOT COMPLETED	Decitabine	0
Randomized Phase III	STARTED	Lead In Phase	0
Randomized Phase III	STARTED	Sapacitabine-decitabine Alternating	241
Randomized Phase III	STARTED	Decitabine	241
Randomized Phase III	COMPLETED	Lead In Phase	0
Randomized Phase III	COMPLETED	Sapacitabine-decitabine Alternating	241
Randomized Phase III	COMPLETED	Decitabine	241
Randomized Phase III	NOT COMPLETED	Lead In Phase	0
Randomized Phase III	NOT COMPLETED	Sapacitabine-decitabine Alternating	0
Randomized Phase III	NOT COMPLETED	Decitabine	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01303796/flow